Centre revokes licences of three vaccine units

The PSUs failed to comply with good manufacturing practices

GN Bureau | March 3, 2010



The centre has lifted the suspension of licences of three public sector vaccine units that were closed in 2008 for failing to comply with good manufacturing practices (GMP). The order will come into effect immediately, reported The Hindu. The licence revocation comes almost two years after the units appealed against their closure.

The ministry of health and family welfare revoked the suspension on February 12 for disposing of stocks both finished products and raw material subject to their being certified fit for human use. The government took into account "the impact in the post-suspension era in terms of availability and prices of these vaccines on the universal immunisation programme and the public interest involved in maintaining the captive production capacity of these units."

The Central Research Institute at Kasauli in Himachal Pradesh, the Pasteur Institute of India at Coonoor in Tamil Nadu and the BCG Vaccine Laboratory in Chennai have been asked to make their production line fully GMP-compliant within three years. They will have to furnish Quarterly reports on the progress made in these three years. Their manufacturing licences were suspended on January 15, 2008.

The suspension of licences of these units came under criticism from Left parties as it resulted in acute shortage and also increased prices in the open market. These units accounted for 80 percent supplies for the universal immunisation programme.

Comments

 

Other News

75 visitors from abroad watch world’s largest elections unfold

As a beacon of electoral integrity and transparency, the Election Commission of India (ECI) exemplifies its commitment to conduct general elections of the highest standards, offering a golden bridge for global Election Management Bodies (EMBs) to witness democratic excellence first-hand. It continues foste

‘Oral cancer deaths in India cause productivity loss of 0.18% GDP’

A first-of-its-kind study on the economic loss due to premature death from oral cancer in India by the Tata Memorial Centre has found that this form of cancer has a premature mortality rate of 75.6% (34 premature events / 45 total events) resulting in productivity loss of approximately $5.6 billion in 2022

Days of Reading: Upendra Baxi recalls works that shaped his youth

Of Law and Life Upendra Baxi in Conversation with Arvind Narrain, Lawrence Liang, Sitharamam Kakarala, and Sruti Chaganti Orient BlackSwan, Rs 2,310

Voting by tribal communities blossoms as ECI’s efforts bear fruit

The efforts made by the Election Commission of India (ECI), over last two years, for inclusion of Particularly Vulnerable Tribal Groups (PVTG) communities and other tribal groups in the electoral process have borne fruit with scenes of tribal groups in various states/UTs participating enthusiastically in t

GST revenue for April 2024 at a new high

The gross Goods and Services Tax (GST) collections hit a record high in April 2024 at ₹2.10 lakh crore. This represents a significant 12.4% year-on-year growth, driven by a strong increase in domestic transactions (up 13.4%) and imports (up 8.3%). After accounting for refunds, the net GST

First Magahi novel presents a glimpse of Bihar bureaucracy a century ago

Fool Bahadur By Jayanath Pati (Translated by Abhay K.) Penguin Modern Classics, 112 pages, Rs 250 “Bab

Visionary Talk: Amitabh Gupta, Pune Police Commissioner with Kailashnath Adhikari, MD, Governance Now


Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter